Podcast Episodes

Back to Search
Revolution Medicines Plummets 17% — The $30 Billion Deal That Vanished

Season 1 Episode 92

Revolution Medicines (RVMD) just saw its stock crater 17% after reports surfaced that Merck has officially pulled the plug on its rumored $30 billion…

9 months, 2 weeks ago

Short Long
View Episode
Legend Biotech Tanks 11% — Dead Money or J&J’s Perfect Acquisition Target?

Season 1 Episode 91

Legend Biotech just slammed into a new 52-week low, plunging 11% after missing sales estimates for its flagship cancer drug, Carvykti. Wall Street’s …

9 months, 3 weeks ago

Short Long
View Episode
AeroVironment Dives 16% — Pentagon "Stop Work" Shock & Merger Indigestion

Season 1 Episode 90

AeroVironment (AVAV) just shed nearly 16% after the U.S. government slammed the brakes with a surprise "Stop Work Order" on its classified BADGER pro…

9 months, 3 weeks ago

Short Long
View Episode
AST SpaceMobile Rockets 14% — The $151 Billion Defense Pivot

Season 1 Episode 89

AST SpaceMobile just defied gravity, surging over 14% to a fresh all-time high after securing a prime spot on the U.S. Missile Defense Agency’s massi…

9 months, 3 weeks ago

Short Long
View Episode
Zegna Drops 13% — Paying LVMH Prices for a "Fixer-Upper"?

Season 1 Episode 88

Ermenegildo Zegna stock has slid nearly 13% from last week’s highs after Bank of America downgraded the luxury house, slapping a sober $10 price targ…

9 months, 3 weeks ago

Short Long
View Episode
Reddit Tumbles 10% — An Identity Crisis: AI Utility or Shaky Ad Play?

Season 1 Episode 87

Reddit just shed nearly 10% of its value in a single session, caught in a brutal tug-of-war between Wall Street analysts. While bulls recently slappe…

9 months, 4 weeks ago

Short Long
View Episode
Trip.com Tanks 20% — Antitrust Probe Shatters the “Safe Play” Myth

Season 1 Episode 86

Trip.com just nose-dived nearly 20% overnight, blindsiding investors with a sudden antitrust investigation from Chinese regulators. It was supposed t…

9 months, 4 weeks ago

Short Long
View Episode
Dave Inc. Craters 23% — Is Wall Street Punishing the Wrong Stock?

Season 1 Episode 85

Dave Inc. (DAVE) just capped off a brutal week, plunging nearly 23% amid Fed controversy and fears of new banking regulations. The twist? The company…

9 months, 4 weeks ago

Short Long
View Episode
Figma Crashes 75% From Peak — The “Broken IPO” or the Ultimate Software Steal?

Season 1 Episode 84

Figma, the design powerhouse that nearly merged with Adobe for $20 billion, is now trading around $36—a staggering 75% drop from its $142 post-IPO hi…

9 months, 4 weeks ago

Short Long
View Episode
Abercrombie Declines 18% — Record Sales Crushed by a $90M Tariff Hit?

Season 1 Episode 83

Abercrombie & Fitch just saw an 18% hole blown in its stock chart, despite reporting record holiday demand. Why the panic? Wall Street is fixating on…

10 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us